| View |
|
DR-XY37151
|
Olmesartan medoxomil + Hydrochlorothiazide
|
Alzor HCT
|
40mg/12.5mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blocker/ Diuretic
|
Ajanta Pharma Limited
|
India
|
Renewal
|
20 October 2024
|
03 December 2029
|
| View |
|
DR-XY37159
|
Olmesartan medoxomil + Hydrochlorothiazide
|
Alzor HCT
|
20 mg/12.5 mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blocker/ Diuretic
|
Ajanta Pharma Limited
|
India
|
Renewal
|
09 October 2024
|
03 December 2029
|
| View |
|
DR-XY37169
|
Betahistine hydrochloride
|
OVERT
|
8mg
|
Tablet
|
Anti-vertigo
|
E.L. Laboratories, Inc.
|
Philippines
|
Renewal
|
27 May 2024
|
04 December 2029
|
| View |
|
DR-XY37173
|
Lisinopril
|
Lisnoxl
|
5 mg
|
Tablet
|
Angiotensin Converting Enzyme (ACE) Inhibitor
|
XL Laboratories Pvt Ltd
|
India
|
Renewal
|
14 February 2024
|
04 December 2029
|
| View |
|
DR-XY37174
|
Potassium Citrate (As Monohydrate)
|
Tascit
|
1080 mg (10 mEq)
|
Extended-Release Tablet
|
-
|
Amherst Laboratories, Inc.
|
philipines
|
-
|
21 February 2020
|
08 December 2024
|
| View |
|
DR-XY37175
|
Betahistine hydrochloride
|
OVERT
|
16 mg
|
Tablet
|
Antivertigo
|
E.L. Laboratories, Inc.
|
Philippines
|
Renewal
|
19 May 2024
|
04 December 2029
|
| View |
|
DR-XY37184
|
CIPROFLOXACIN (as Hydrochloride) DEXAMETHASONE
|
Unbranded
|
3mg/1mg per mL (0.3% w/v /0.1% w/v)
|
Sterile Ophthalmic Suspension (Eye Drops)
|
ANTIBACTERIAL/ ANTI-INFLAMMATORY
|
El Laboratories, Inc
|
Philippines
|
Renewal
|
04 August 2024
|
08 December 2029
|
| View |
|
DR-XY37186
|
Fluticasone Propionate
|
Primair
|
125 mcg per actuation
|
Metered-Dose Inhaler
|
-
|
Medispray Laboratories Pvt. Ltd.
|
India
|
-
|
04 February 2020
|
08 December 2024
|
| View |
|
DR-XY37200
|
Timolol Maleate
|
Timabak
|
5mg/mL (0.5% w/v)
|
Ophthalmic Solution (Eye Drops)
|
Beta-Adrenoceptor Blocker
|
Excelvision
|
France
|
Renewal
|
04 August 2024
|
10 December 2029
|
| View |
|
DR-XY37201
|
Glimepiride
|
Neoacotril
|
3mg
|
Tablet
|
-
|
Hizon Laboratories, Inc.
|
Philippines
|
-
|
15 April 2020
|
10 December 2024
|
| View |
|
DR-XY37204
|
Amlodipine (as Besilate)
|
Besylon
|
5 mg
|
Film-Coated Tablet
|
Antihypertensive (Calcium Channel Blocker)
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
04 August 2024
|
15 December 2029
|
| View |
|
DR-XY37205
|
Co-Amoxiclav
|
Vamox
|
400mg/ 57mg/ 5mL
|
Powder for Suspension
|
Antibacterial (Penicillin)
|
Drugmaker's Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
21 December 2021
|
22 December 2026
|
| View |
|
DR-XY37211
|
Cinnarizine
|
Unbranded
|
25 mg
|
Tablet
|
Antivertigo
|
UNILAB, Inc.
|
Philippines
|
Renewal
|
12 October 2024
|
18 December 2029
|
| View |
|
DR-XY37216
|
Sildenafil citrate
|
Zilden
|
50 mg
|
Film-Coated Tablet
|
Phosphodiesterase Type-5 (PDE-5) Inhibitor
|
Pascual Laboratories Inc
|
Philippines
|
Renewal
|
15 September 2024
|
18 December 2029
|
| View |
|
DR-XY37225
|
Citicoline (as sodium)
|
Miracoline
|
500 mg
|
Capsule
|
Psychostimulant/Nootropic
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
11 August 2024
|
18 December 2029
|
| View |
|
DR-XY37227
|
Tetrahydrozoline Hydrochloride
|
Visine
|
0.5mg/ mL
|
Solution
|
-
|
PT Pfizer Indonesia
|
Indonesia
|
Automatic Renewal
|
14 October 2022
|
31 January 2027
|
| View |
|
DR-XY37238
|
Fluocinonide
|
Frostlike
|
250mcg/g
|
Ointment
|
-
|
Tianjin Pacific Pharmaceutical Co. Ltd.
|
China
|
-
|
26 December 2019
|
21 December 2024
|
| View |
|
DR-XY37250
|
Fosinopril Sodium
|
Bp Norm
|
10 mg
|
Tablet
|
-
|
Amherst Laboratories, Inc.
|
Philippines
|
-
|
27 December 2019
|
21 December 2024
|
| View |
|
DR-XY37253
|
Multivitamins + Minerals + Korean Ginseng + Royal Jelly
|
Vitagin
|
(see reverse)
|
Softgel Capsule
|
-
|
Daewon Pharm. Co. Ltd.
|
Korea
|
-
|
24 September 2019
|
23 December 2024
|
| View |
|
DR-XY37275
|
Phenytoin (as sodium)
|
Unbranded
|
50 mg/ mL (100 mg/ 2 mL)
|
Solution For Injection
|
Antivertigo
|
Amherst Laboratories Inc.
|
Philippines
|
Renewal
|
21 October 2024
|
29 December 2029
|